Investing.com – P3 Health Partners reported on Monday third quarter that missed analysts’ forecasts and revenue that topped expectations.

P3 Health Partners announced earnings per share of $-0.27 on revenue of $248.26M. Analysts polled by Investing.com anticipated EPS of $-0.21 on revenue of $243.5M.

P3 Health Partners shares are down 81% from the beginning of the year and are trading at $4.94 , down-from-52-week-high.

P3 Health Partners shares gained 0.20% in after-hours trade the report.

P3 Health Partners follows other major Healthcare sector earnings this month

P3 Health Partners’s report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, compared to forecasts EPS of $2.48 on revenue of $23.36B.

Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, compared to forecast for EPS of $1.91 on revenue of $6.91B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar